[HTML][HTML] Practice advisory update summary: patent foramen ovale and secondary stroke prevention: report of the Guideline Subcommittee of the American Academy of …
SR Messé, GS Gronseth, DM Kent, JR Kizer… - Neurology, 2020 - ncbi.nlm.nih.gov
Objective To update the 2016 American Academy of Neurology (AAN) practice advisory for
patients with stroke and patent foramen ovale (PFO). Methods The guideline panel followed …
patients with stroke and patent foramen ovale (PFO). Methods The guideline panel followed …
Second consensus document on diagnosis and management of acute deep vein thrombosis: updated document elaborated by the ESC Working Group on aorta and …
L Mazzolai, W Ageno, A Alatri… - European journal of …, 2022 - academic.oup.com
This consensus document is proposed to clinicians to provide the whole spectrum of deep
vein thrombosis management as an update to the 2017 consensus document. New data …
vein thrombosis management as an update to the 2017 consensus document. New data …
[HTML][HTML] Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: executive summary of a European and Asia-Pacific expert …
While there is a clear clinical benefit of oral anticoagulation in patients with atrial fibrillation
(AF) and venous thromboembolism (VTE) in reducing the risks of thromboembolism, major …
(AF) and venous thromboembolism (VTE) in reducing the risks of thromboembolism, major …
Diagnosis and treatment of lower extremity venous thromboembolism: a review
R Chopard, IE Albertsen, G Piazza - Jama, 2020 - jamanetwork.com
Importance Incidence rates for lower extremity deep vein thrombosis (DVT) range from 88 to
112 per 100 000 person-years and increase with age. Rates of recurrent VTE range from …
112 per 100 000 person-years and increase with age. Rates of recurrent VTE range from …
[HTML][HTML] Platelets and their role in hemostasis and thrombosis—From physiology to pathophysiology and therapeutic implications
A Scridon - International Journal of Molecular Sciences, 2022 - mdpi.com
Hemostasis is a physiological process critical for survival. Meanwhile, thrombosis is
amongst the leading causes of death worldwide, making antithrombotic therapy one of the …
amongst the leading causes of death worldwide, making antithrombotic therapy one of the …
[HTML][HTML] Platelet in thrombo-inflammation: Unraveling new therapeutic targets
In the broad range of human diseases, thrombo-inflammation appears as a clinical
manifestation. Clinically, it is well characterized in context of superficial thrombophlebitis that …
manifestation. Clinically, it is well characterized in context of superficial thrombophlebitis that …
[PDF][PDF] Deep vein thrombosis: update on diagnosis and management
PC Kruger, JW Eikelboom, JD Douketis… - Medical Journal of …, 2019 - mja.com.au
Deep vein thrombosis: update on diagnosis and management Page 1 Narrative review MJA 2 10
(11) ▪ 17 June 2 0 19 Deep vein thrombosis: update on diagnosis and management Paul C …
(11) ▪ 17 June 2 0 19 Deep vein thrombosis: update on diagnosis and management Paul C …
[PDF][PDF] Validating the HERDOO2 rule to guide treatment duration for women with unprovoked venous thrombosis: multinational prospective cohort management study
Objective To prospectively validate the HERDOO2 rule (Hyperpigmentation, Edema, or
Redness in either leg; D-dimer level≥ 250 μg/L; Obesity with body mass index≥ 30; or …
Redness in either leg; D-dimer level≥ 250 μg/L; Obesity with body mass index≥ 30; or …
[HTML][HTML] The dual role of platelet‐innate immune cell interactions in thrombo‐inflammation
Beyond their role in hemostasis and thrombosis, platelets are increasingly recognized as
key regulators of the inflammatory response under sterile and infectious conditions. Both …
key regulators of the inflammatory response under sterile and infectious conditions. Both …